Main > ONCOLOGY (**) > Kidney Cancer>RCC>MET *** > Treatment > USA. B. IpilimuMAb+NivoluMAb***

---

USA. B. IpilimuMAb+NivoluMAb***'s subsections
(*) EU Approval Date: 2019. 01.14.
Company
IpilimuMAb TradeMark
NivoluMAb TradeMark
PR Web-Site

USA. B. IpilimuMAb+NivoluMAb***'s products
This section has no products